68 related articles for article (PubMed ID: 25595713)
21. Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model.
Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
J Antimicrob Chemother; 2008 Nov; 62(5):1078-85. PubMed ID: 18772161
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of different methods for detection of Clostridium difficile toxins in Poland.
Martirosian G; Pituch H; Obuch-Woszczatyński P; Rouyan G; Meisel-Mikołajczyk F
Acta Microbiol Pol; 1999; 48(4):349-53. PubMed ID: 10756719
[TBL] [Abstract][Full Text] [Related]
23. Clostridium difficile-associated diarrhoea.
Elliott B; Chang BJ; Golledge CL; Riley TV
Intern Med J; 2007 Aug; 37(8):561-8. PubMed ID: 17640189
[TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile infection.
Kelly CP; LaMont JT
Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
[TBL] [Abstract][Full Text] [Related]
25. [Clostridium difficile infection. The nosocomial aspect].
Bucher A; Nordbø G
Tidsskr Nor Laegeforen; 1995 Apr; 115(11):1361-4. PubMed ID: 7770832
[TBL] [Abstract][Full Text] [Related]
26. Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.
Norén T; Wullt M; Akerlund T; Bäck E; Odenholt I; Burman LG
Antimicrob Agents Chemother; 2006 Sep; 50(9):3028-32. PubMed ID: 16940098
[TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus.
Asha NJ; Tompkins D; Wilcox MH
J Clin Microbiol; 2006 Aug; 44(8):2785-91. PubMed ID: 16891493
[TBL] [Abstract][Full Text] [Related]
28. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile.
Lemee L; Dhalluin A; Testelin S; Mattrat MA; Maillard K; Lemeland JF; Pons JL
J Clin Microbiol; 2004 Dec; 42(12):5710-4. PubMed ID: 15583303
[TBL] [Abstract][Full Text] [Related]
29. Clostridium difficile infections in HIV-positive patients with diarrhoea.
Kumar N; Ekka M; P R; Ranjan S; Sinha S; Sharma SK; Chaudhry R; Sharma N; Ahmad H; Samantaray JC; Sreenivas V
Natl Med J India; 2014; 27(3):138-40. PubMed ID: 25668083
[TBL] [Abstract][Full Text] [Related]
30. Yeast, beef and pork extracts counteract Clostridium difficile toxin A enterotoxicity.
Duncan PI; Fotopoulos G; Pasche E; Porta N; Masserey Elmelegy I; Sanchez-Garcia JL; Bergonzelli GE; Corthésy-Theulaz I
FEMS Microbiol Lett; 2009 Jun; 295(2):218-25. PubMed ID: 19416358
[TBL] [Abstract][Full Text] [Related]
31. Intravenous immunoglobulin for resistant Clostridium difficile infection.
Murphy C; Vernon M; Cullen M
Age Ageing; 2006 Jan; 35(1):85-6. PubMed ID: 16303776
[TBL] [Abstract][Full Text] [Related]
32. Recent trends in diagnosis and treatment of Clostridium difficile in a tertiary care facility.
Butterworth SA; Koppert E; Clarke A; Wiggs B; MacFarlane JK
Am J Surg; 1998 May; 175(5):403-7. PubMed ID: 9600288
[TBL] [Abstract][Full Text] [Related]
33. Inappropriate use of loperamide worsens Clostridium difficile-associated diarrhoea.
Kato H; Kato H; Iwashima Y; Nakamura M; Nakamura A; Ueda R
J Hosp Infect; 2008 Oct; 70(2):194-5. PubMed ID: 18694612
[No Abstract] [Full Text] [Related]
34. Flow cytometric analysis of Clostridium difficile adherence to human intestinal epithelial cells.
Drudy D; O'Donoghue DP; Baird A; Fenelon L; O'Farrelly C
J Med Microbiol; 2001 Jun; 50(6):526-534. PubMed ID: 11393290
[TBL] [Abstract][Full Text] [Related]
35. Effects of epidermal growth factor and Clostridium difficile toxin B in a model of mucosal injury.
Lawrence JP; Brevetti L; Obiso RJ; Wilkins TD; Kimura K; Soper R
J Pediatr Surg; 1997 Mar; 32(3):430-3. PubMed ID: 9094010
[TBL] [Abstract][Full Text] [Related]
36. Lactoferrin-Loaded Alginate Microparticles to Target Clostridioides difficile Infection.
Braim S; Śpiewak K; Brindell M; Heeg D; Alexander C; Monaghan T
J Pharm Sci; 2019 Jul; 108(7):2438-2446. PubMed ID: 30851342
[TBL] [Abstract][Full Text] [Related]
37. Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat.
Izadnia F; Wong CT; Kocoshis SA
Dig Dis Sci; 1998 Sep; 43(9):2055-60. PubMed ID: 9753273
[TBL] [Abstract][Full Text] [Related]
38. A tertiary amino-containing polymethacrylate polymer protects mucus-covered intestinal epithelial monolayers against pathogenic challenge.
Keely S; Rawlinson LA; Haddleton DM; Brayden DJ
Pharm Res; 2008 May; 25(5):1193-201. PubMed ID: 18046631
[TBL] [Abstract][Full Text] [Related]
39. Differentiating ischemic colitis from other colitides.
Orikasa H; Katayama I
Am J Surg Pathol; 1998 Jun; 22(6):773-4. PubMed ID: 9630187
[No Abstract] [Full Text] [Related]
40. Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by
Gigli S; Seguella L; Pesce M; Bruzzese E; D'Alessandro A; Cuomo R; Steardo L; Sarnelli G; Esposito G
United European Gastroenterol J; 2017 Dec; 5(8):1108-1115. PubMed ID: 29238589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
